Literature DB >> 11764078

Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities.

M Onciu1, E Schlette, L J Medeiros, L V Abruzzo, M Keating, R Lai.   

Abstract

We compared conventional cytogenetic findings in mantle cell lymphomas (MCLs) having an absolute peripheral lymphocytosis of more than 10,000/microL (>10 x 10(9)/L) at diagnosis ("leukemic"; n = 30) with those in cases having no or minimal lymphocytosis ("nodal"; n = 19). Only cases positive for t(11;14) were included for study. Forty-six cases (94%) had abnormalities in addition to t(11;14). The most frequent abnormalities involved chromosome 13 (26 cases [53%]), followed by chromosomes 1, 3, 7, 8, 9, 10, 12, 15, 17, and 21 (11-18 cases [22%-37%]). There was no difference in the number of aberrations between the 2 groups. Abnormalities of chromosomes 17, 21, and 22 were more frequent, and breakpoints involving 8q24, 9p22-24, and 16q24 were found exclusively in leukemic MCL. Chromosome 17 aberrations involved were structural (breakpoints involving 17p13, 17p11.2, 17q) in leukemic MCL but were only numeric in nodal MCL. Thus, leukemic MCL differs from nodal MCL in their cytogenetic profiles, which may contribute to the clinical presentation.

Entities:  

Mesh:

Year:  2001        PMID: 11764078     DOI: 10.1309/JQMR-323G-71Y9-M7MB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.

Authors:  Armen Kasyan; L Jeffrey Medeiros; Zhuang Zuo; Favio P Santos; Farhad Ravandi-Kashani; Roberto Miranda; Saroj Vadhan-Raj; Hartmut Koeppen; Carlos E Bueso-Ramos
Journal:  Mod Pathol       Date:  2010-05-14       Impact factor: 7.842

2.  Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.

Authors:  Mariko Yabe; L Jeffrey Medeiros; Yahya Daneshbod; Masoud Davanlou; Carlos E Bueso-Ramos; Elisa J Moran; Ken H Young; Roberto N Miranda
Journal:  Ann Diagn Pathol       Date:  2016-10-18       Impact factor: 2.090

3.  Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.

Authors:  Daniel Martín-Pérez; Esther Sánchez; Lorena Maestre; Javier Suela; Pierfrancesco Vargiu; Lorena Di Lisio; Nerea Martínez; Javier Alves; Miguel A Piris; Margarita Sánchez-Beato
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

4.  Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.

Authors:  Sergej Konoplev; C Cameron Yin; Steven M Kornblau; Hagop M Kantarjian; Marina Konopleva; Michael Andreeff; Gary Lu; Zhuang Zuo; Rajyalakshmi Luthra; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Leuk Lymphoma       Date:  2012-07-09

Review 5.  Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature.

Authors:  Reza Setoodeh; Stuart Schwartz; Peter Papenhausen; Ling Zhang; Elizabeth M Sagatys; Lynn C Moscinski; Haipeng Shao
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

6.  Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.

Authors:  Sergej Konoplev; Xuelin Huang; Harry A Drabkin; Hartmut Koeppen; Dan Jones; Hagop M Kantarjian; Guillermo Garcia-Manero; Weina Chen; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

7.  CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.

Authors:  Zhihong Hu; Yi Sun; Ellen J Schlette; Guilin Tang; Shaoying Li; Jie Xu; C Cameron Yin; Ken H Young; Keyur Pravinchandra Patel; Roberto N Miranda; Maitrayee Goswami; Michael Wang; Jeffrey L Jorgensen; L Jeffrey Medeiros; Sa A Wang
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

8.  Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression.

Authors:  Wei Cui; Carlos E Bueso-Ramos; C Cameron Yin; Jianlan Sun; Su Chen; Ramya Muddasani; Gary Lu
Journal:  J Biomed Biotechnol       Date:  2011-01-20

9.  MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma.

Authors:  Lifu Wang; Guilin Tang; L Jeffrey Medeiros; Jie Xu; Wenting Huang; Cameron C Yin; Michael Wang; Preetesh Jain; Pei Lin; Shaoying Li
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

10.  De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Eman Al Mussaed; Hassan Aljasem; Sultan Alotaibi; Hatem Elghezal
Journal:  Case Rep Hematol       Date:  2015-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.